Results 251 to 260 of about 553,897 (314)

Changes in MELD-Na & Fibroscan Scores in Patients with Chronic Hepatitis-B on Entecavir: A Cohort Analysis. [PDF]

Pak J Med Sci
Zuberi BF, Ali FS, Rasheed T, Bader N.
europepmc   +1 more source

Use of FK 506 in the treatment of liver allograft rejection [PDF]

, 1991
Bronsther, O, Casavilla, A, Demetris, A, Doyle, H, Fung, J, Gordon, R, Imventarza, O, Iwatsuki, S, Martin, M, Reyes, J, Selby, R, Starzl, TE, Stieber, A, Todo, S, Tzakis, A   +14 more
core  

Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]

Front Med (Lausanne)
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc   +1 more source

Prevalence and Spectrum of Chronic Liver Disease Among Patients Seeking Health Care in Ghana. [PDF]

Liver Int
Lehmann F, Killer A, Wels S, Schmiedel S, Phillips RO, Roppert PL, Eberhardt KA, Holtfreter MC, Stauga S, Lohse AW, Ehrhardt S, Opare-Sem O, Orth HM, Sarfo FS, Drosten C, Eis-Hübinger AM, Luedde T, Glebe D, Drexler JF, Feldt T.   +19 more
europepmc   +1 more source

Skin Fragility and Hyperpigmentation in a Patient With HIV

JEADV Clinical Practice, EarlyView.
Catalina Retamal, Maximiliano Maass, María Fernanda Martin   +2 more
wiley   +1 more source

Correction to: Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D). [PDF]

Open Forum Infect Dis
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic hepatic porphyria in chronic aggressive hepatitis

Klinische Wochenschrift, 1971
An acquired (“symptomatic”) chronic hepatic porphyria (CHP) is described, which develops secondarily following damage to the liver tissue and is characterized by the absence of clinical symptoms. It can be differentiated biochemically from latent porphyria cutanea tarda (PCT) by a lower total porphyrin excretion (0.18–0.64 mg/l) and a relatively ...
M, Doss, D, Look, H, Henning
openaire   +2 more sources